FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1862504835> ?p ?o ?g. }

• W1862504835 endingPage "E157" @default.
• W1862504835 startingPage "E152" @default.
• W1862504835 abstract "What's known on the subject? and What does the study add? Testicular cancer is a chemosensitive disease. Treatment with primary chemotherapy leads to eradication of metastatic disease and high cure rates. Completion orchidectomy is usually performed after primary chemotherapy with viable tumour and teratoma often identified in the orchidectomy specimen. The need for completion orchidectomy in patients with a complete response to systemic chemotherapy is uncertain. The present study confirms the discordance in pathology in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection (RPLND) after chemotherapy for metastatic disease. Viable tumour is frequently present in the testis despite tumour-free RPLNs. These findings support the need for completion orchidectomy as part of the management for advanced testicular germ cell cancer. OBJECTIVE • To determine the differential response to systemic chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection (RPLND) after chemotherapy for metastatic testicular cancer. PATIENTS AND METHODS • Patients who underwent simultaneous RPLND and orchidectomy after chemotherapy were identified from our clinical databases. • Postoperative pathological findings and patient characteristics were reviewed. RESULTS • In all, 42 patients were identified. • After chemotherapy, necrosis, teratoma and cancer were identified in 25 (59.5%), 14 (33.3%) and three (7.1%) RPLN specimens and 15 (35.7%), 15 (35.7%) and 12 (28.6%) orchidectomy specimens respectively. • Of the 25 patients with necrotic RPLN specimens 12 (48.0%) had active disease within the orchidectomy specimen (eight invasive cancer and four mature teratoma). • The overall histological discordance rate was 38.1%. Findings in the orchidectomy specimens were more aggressive than those in the RPLN specimens (i.e. cancer worse than teratoma, which is worse than necrosis) in 33.3%. CONCLUSIONS • There is significant disparity between orchidectomy and RPLND findings with viable tumour appearing frequently in the testis despite tumour-free RPLNs. • These findings support completion orchidectomy as part of advanced testicular germ cell treatment." @default.
• W1862504835 created "2016-06-24" @default.
• W1862504835 creator A5031050958 @default.
• W1862504835 creator A5035580367 @default.
• W1862504835 creator A5036463446 @default.
• W1862504835 creator A5047234703 @default.
• W1862504835 creator A5047753094 @default.
• W1862504835 creator A5064459524 @default.
• W1862504835 date "2012-09-27" @default.
• W1862504835 modified "2023-10-18" @default.
• W1862504835 title "Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours" @default.
• W1862504835 cites W139154273 @default.
• W1862504835 cites W1563506960 @default.
• W1862504835 cites W1838921188 @default.
• W1862504835 cites W1840867835 @default.
• W1862504835 cites W1885131295 @default.
• W1862504835 cites W1926135291 @default.
• W1862504835 cites W1964470226 @default.
• W1862504835 cites W1969723909 @default.
• W1862504835 cites W1992735863 @default.
• W1862504835 cites W2026102604 @default.
• W1862504835 cites W2032233870 @default.
• W1862504835 cites W2062428746 @default.
• W1862504835 cites W2073146168 @default.
• W1862504835 cites W2077693937 @default.
• W1862504835 cites W2078877172 @default.
• W1862504835 cites W2080126067 @default.
• W1862504835 cites W2089925296 @default.
• W1862504835 cites W2106496119 @default.
• W1862504835 cites W2107207009 @default.
• W1862504835 cites W2136564762 @default.
• W1862504835 cites W2142527252 @default.
• W1862504835 cites W2143535850 @default.
• W1862504835 cites W2146153797 @default.
• W1862504835 cites W2168399625 @default.
• W1862504835 cites W2230503432 @default.
• W1862504835 cites W2270278493 @default.
• W1862504835 cites W2276127942 @default.
• W1862504835 cites W2299967106 @default.
• W1862504835 cites W2432246021 @default.
• W1862504835 cites W4297914219 @default.
• W1862504835 cites W4319054745 @default.
• W1862504835 cites W4382915988 @default.
• W1862504835 doi "https://doi.org/10.1111/j.1464-410x.2012.11537.x" @default.
• W1862504835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23016566" @default.
• W1862504835 hasPublicationYear "2012" @default.
• W1862504835 type Work @default.
• W1862504835 sameAs 1862504835 @default.
• W1862504835 citedByCount "12" @default.
• W1862504835 countsByYear W18625048352013 @default.
• W1862504835 countsByYear W18625048352016 @default.
• W1862504835 countsByYear W18625048352017 @default.
• W1862504835 countsByYear W18625048352018 @default.
• W1862504835 countsByYear W18625048352019 @default.
• W1862504835 countsByYear W18625048352021 @default.
• W1862504835 countsByYear W18625048352022 @default.
• W1862504835 crossrefType "journal-article" @default.
• W1862504835 hasAuthorship W1862504835A5031050958 @default.
• W1862504835 hasAuthorship W1862504835A5035580367 @default.
• W1862504835 hasAuthorship W1862504835A5036463446 @default.
• W1862504835 hasAuthorship W1862504835A5047234703 @default.
• W1862504835 hasAuthorship W1862504835A5047753094 @default.
• W1862504835 hasAuthorship W1862504835A5064459524 @default.
• W1862504835 hasConcept C141071460 @default.
• W1862504835 hasConcept C142724271 @default.
• W1862504835 hasConcept C207886595 @default.
• W1862504835 hasConcept C2775862295 @default.
• W1862504835 hasConcept C2776057878 @default.
• W1862504835 hasConcept C2776212926 @default.
• W1862504835 hasConcept C2776694085 @default.
• W1862504835 hasConcept C2776938808 @default.
• W1862504835 hasConcept C2779511695 @default.
• W1862504835 hasConcept C2780849966 @default.
• W1862504835 hasConcept C2781440318 @default.
• W1862504835 hasConcept C71924100 @default.
• W1862504835 hasConceptScore W1862504835C141071460 @default.
• W1862504835 hasConceptScore W1862504835C142724271 @default.
• W1862504835 hasConceptScore W1862504835C207886595 @default.
• W1862504835 hasConceptScore W1862504835C2775862295 @default.
• W1862504835 hasConceptScore W1862504835C2776057878 @default.
• W1862504835 hasConceptScore W1862504835C2776212926 @default.
• W1862504835 hasConceptScore W1862504835C2776694085 @default.
• W1862504835 hasConceptScore W1862504835C2776938808 @default.
• W1862504835 hasConceptScore W1862504835C2779511695 @default.
• W1862504835 hasConceptScore W1862504835C2780849966 @default.
• W1862504835 hasConceptScore W1862504835C2781440318 @default.
• W1862504835 hasConceptScore W1862504835C71924100 @default.
• W1862504835 hasIssue "4b" @default.
• W1862504835 hasLocation W18625048351 @default.
• W1862504835 hasLocation W18625048352 @default.
• W1862504835 hasOpenAccess W1862504835 @default.
• W1862504835 hasPrimaryLocation W18625048351 @default.
• W1862504835 hasRelatedWork W101130268 @default.
• W1862504835 hasRelatedWork W2027775279 @default.
• W1862504835 hasRelatedWork W2050451030 @default.
• W1862504835 hasRelatedWork W2080603030 @default.
• W1862504835 hasRelatedWork W2115745302 @default.
• W1862504835 hasRelatedWork W2146153797 @default.

• next